Bacterial infections in cirrhosis

Area of Science:

• Hepatology
• Infectious Diseases
• Critical Care Medicine

Background:

• Bacterial infections affect 25-35% of hospitalized cirrhotics.
• Nosocomial infections are most common, with spontaneous bacterial peritonitis and urinary tract infections being frequent sites.
• Risk factors include severe liver disease and prior infections.

Purpose of the Study:

• To review the epidemiology, outcomes, and management of bacterial infections in cirrhosis.
• To highlight the challenges posed by multidrug-resistant organisms.
• To discuss the role of antibiotic prophylaxis and albumin therapy.

Main Methods:

• Literature review and synthesis of existing data on infections in cirrhosis.
• Analysis of common pathogens in community-acquired versus nosocomial infections.
• Evaluation of the impact of infections on liver function, mortality, and complications.

Main Results:

• Gram-negative bacteria are common in community-acquired infections, while Gram-positive bacteria dominate nosocomial infections.
• Up to 30% of hospital-acquired infections involve multidrug-resistant bacteria.
• Infections significantly increase in-hospital and 1-year mortality, with multidrug-resistant infections leading to worse outcomes.

Conclusions:

• Infections are a major cause of morbidity and mortality in cirrhosis.
• Antibiotic prophylaxis strategies, including short-term for gastrointestinal bleeding and long-term for spontaneous bacterial peritonitis, improve survival.
• Albumin administration shows survival benefits in spontaneous bacterial peritonitis and advanced liver disease.